Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' BIEGON A' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 44 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Biegon, A; Kerman, IA
      Autoradiographic study of pre- and postnatal distribution of cannabinoid receptors in human brain

      NEUROIMAGE
    2. Fowler, JS; Logan, J; Ding, YS; Franceschi, D; Wang, GJ; Volkow, ND; Pappas, N; Schlyer, D; Gatley, SJ; Alexoff, D; Felder, C; Biegon, A; Zhu, W
      Non-MAO A binding of clorgyline in white matter in human brain

      JOURNAL OF NEUROCHEMISTRY
    3. Gross-Isseroff, R; Weizman, A; Fieldust, SJ; Israeli, M; Biegon, A
      Unaltered alpha(2)-noradrenergic/imidazoline receptors in suicide victims:a postmortem brain autoradiographic analysis

      EUROPEAN NEUROPSYCHOPHARMACOLOGY
    4. Shapiro, J; Belmaker, RH; Biegon, A; Seker, A; Agam, G
      Scyllo-inositol in post-mortem brain of bipolar, unipolar and schizophrenic patients

      JOURNAL OF NEURAL TRANSMISSION
    5. Achiron, A; Miron, S; Lavie, V; Margalit, R; Biegon, A
      Dexanabinol (HU-211) effect on experimental autoimmune encephalomyelitis: implications for the treatment of acute relapses of multiple sclerosis

      JOURNAL OF NEUROIMMUNOLOGY
    6. Pop, E; Rachwal, S; Vlasak, J; Biegon, A; Zharikova, A; Prokai, L
      In vitro and in vivo study of water-soluble prodrugs of dexanabinol

      JOURNAL OF PHARMACEUTICAL SCIENCES
    7. STRIEM S; BARJOSEPH A; KLOOG Y; POP E; BIEGON A
      A QUATERNIZED TAMOXIFEN ANALOG, TAMOXIFEN METHYL-IODIDE (TMI), INHIBITS GROWTH OF CANCER IN-VIVO AND IN-VITRO, IN A DIFFERENT MANNER THAN TAMOXIFEN

      Annals of oncology
    8. GROSSISSEROFF R; BIEGON A; VOET H; WEIZMAN A
      THE SUICIDE BRAIN - A REVIEW OF POSTMORTEM RECEPTOR TRANSPORTER BINDING-STUDIES/

      Neuroscience and biobehavioral reviews
    9. BARJOSEPH A; BERCKOVITCH Y; LAVIE V; WEXLER A; YOGEV A; AMSELEM S; BIEGON A
      INTRACOLONIC ADMINISTRATION OF DEXANABINOL REDUCES PATHOLOGICAL OUTCOME IN ACETIC ACID-INDUCED INFLAMMATORY BOWEL-DISEASE IN RATS

      Naunyn-Schmiedeberg's archives of pharmacology
    10. BREWSTER ME; POP E; FOLTZ RL; REUSCHEL S; GRIFFITH W; AMSELEM S; BIEGON A
      CLINICAL PHARMACOKINETICS OF ESCALATING IV DOSES OF DEXANABINOL (HU-211), A NEUROPROTECTANT AGENT, IN NORMAL VOLUNTEERS

      International journal of clinical pharmacology and therapeutics
    11. SIEGAL T; SOTI F; BIEGON A; POP E; BREWSTER ME
      EFFECT OF A CHEMICAL DELIVERY SYSTEM FOR DEXAMETHASONE (DEX-CDS) ON PERITUMORAL EDEMA IN AN EXPERIMENTAL BRAIN-TUMOR MODEL

      Pharmaceutical research
    12. BREWSTER ME; PARAN Y; RUSHKIN E; BIEGON A; POP E; DEGANI H
      EVALUATION OF THE ANTICANCER ACTION OF A PERMANENTLY CHARGED TAMOXIFEN DERIVATIVE, TAMOXIFEN METHIODIDE - AN MRI STUDY

      International journal of pharmaceutics
    13. LAVIE V; WEKSLER A; MARGALIT R; ACHIRON A; MIRON S; BIEGON A
      THE EFFECT OF DEXANABINOL (HU-211) IN A RAT MODEL OF EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS

      Neuroscience letters
    14. POP E; SOTI F; BIEGON A; BREWSTER ME
      ALLYLIC AND PHENOLIC PHOSPHATE-ESTERS OF DEXANABINOL

      Organic preparations and procedures international
    15. GALLILY R; YAMIN A; WAKSMANN Y; OVADIA H; WEIDENFELD J; BARJOSEPH A; BIEGON A; MECHOULAM R; SHOHAMI E
      PROTECTION AGAINST SEPTIC SHOCK AND SUPPRESSION OF TUMOR-NECROSIS-FACTOR-ALPHA AND NITRIC-OXIDE PRODUCTION BY DEXANABINOL (HU-211), A NONPSYCHOTROPIC CANNABINOID

      The Journal of pharmacology and experimental therapeutics
    16. BARPELED O; BENHUR H; BIEGON A; GRONER Y; DEWHURST S; FURUTA A; ROTHSTEIN JD
      DISTRIBUTION OF GLUTAMATE TRANSPORTER SUBTYPES DURING HUMAN BRAIN-DEVELOPMENT

      Journal of neurochemistry
    17. STRIEM S; BARJOSEPH A; BERKOVITCH Y; BIEGON A
      INTERACTION OF DEXANABINOL (HU-211), A NOVEL NMDA RECEPTOR ANTAGONIST, WITH THE DOPAMINERGIC SYSTEM

      European journal of pharmacology
    18. POP E; BROWNE CE; NADLER V; BIEGON A; BREWSTER ME
      NEUROPROTECTIVE (-SIDE CHAIN() 3S, 4S CANNABINOIDS WITH MODIFIED 5')

      Bioorganic & medicinal chemistry letters
    19. POP E; SOTI F; BREWSTER ME; BARENHOLZ Y; KORABLYOV V; MECHOULAM R; NADLER V; BIEGON A
      DERIVATIVES OF DEXANABINOL .2. SALTS OF AMINO-ACID ESTERS CONTAINING TERTIARY AND QUATERNARY HETEROCYCLIC NITROGEN WITH INCREASED WATER-SOLUBILITY

      Pharmaceutical research
    20. POP E; LIU ZZ; BREWSTER ME; BARENHOLZ Y; KORABLYOV V; MECHOULAM R; NADLER V; BIEGON A
      DERIVATIVES OF DEXANABINOL .1. WATER-SOLUBLE SALTS OF GLYCINATE ESTERS

      Pharmaceutical research
    21. JAGUST WJ; EBERLING JL; BIEGON A; TAYLOR SE; VANBROCKLIN HF; JORDAN S; HANRAHAN SM; ROBERTS JA; BRENNAN KM; MATHIS CA
      IODINE-123-5-IODO-6-NITROQUIPAZINE - SPECT RADIOTRACER TO IMAGE THE SEROTONIN TRANSPORTER

      The Journal of nuclear medicine
    22. ENAS JD; CLARK RD; VANBROCKLIN HF; BIEGON A; HANRAHAN SM; BUDINGER TF
      SYNTHESIS AND BIOLOGICAL EVALUATION OF [F-18] RS-15385-FP - A POTENT AND SELECTIVE ALPHA-2-ADRENERGIC RECEPTOR RADIOLIGAND FOR PET

      The Journal of nuclear medicine
    23. BIEGON A
      NEUROCHEMICAL IMAGING OF THE BRAIN IN HEALTH AND DISEASE

      Israel journal of medical sciences
    24. BIEGON A; BREWSTER M; DEGANI H; POP E; SOMJEN D; KAYE AM
      A PERMANENTLY CHARGED TAMOXIFEN DERIVATIVE DISPLAYS ANTICANCER ACTIVITY AND IMPROVED TISSUE SELECTIVITY IN RODENTS

      Cancer research
    25. BELAYEV L; BARJOSEPH A; ADAMCHIK J; BIEGON A
      HU-211, A NONPSYCHOTROPIC CANNABINOID, IMPROVES NEUROLOGICAL SIGNS AND REDUCES BRAIN-DAMAGE AFTER SEVERE FOREBRAIN ISCHEMIA IN RATS

      Molecular and chemical neuropathology
    26. MIZRACHI Y; RUBINSTEIN A; HARISH Z; BIEGON A; ANDERSON WR; BREWSTER ME
      IMPROVED BRAIN DELIVERY AND IN-VITRO ACTIVITY OF ZIDOVUDINE THROUGH THE USE OF A REDOX CHEMICAL DELIVERY SYSTEM

      AIDS
    27. BIEGON A; JOSEPH AB
      DEVELOPMENT OF HU-211 AS A NEUROPROTECTANT FOR ISCHEMIC BRAIN-DAMAGE

      Neurological research
    28. ESHHAR N; STRIEM S; KOHEN R; TIROSH O; BIEGON A
      NEUROPROTECTIVE AND ANTIOXIDANT ACTIVITIES OF HU-211, A NOVEL NMDA RECEPTOR ANTAGONIST

      European journal of pharmacology
    29. NADLER V; BIEGON A; BEITYANNAI E; ADAMCHIK J; SHOHAMI E
      CA-45 ACCUMULATION IN RAT-BRAIN AFTER CLOSED-HEAD INJURY - ATTENUATION BY THE NOVEL NEUROPROTECTIVE AGENT HU-211

      Brain research
    30. BLUMENSOHN R; RATZONI G; WEIZMAN A; ISRAELI M; GREUNER N; APTER A; TYANO S; BIEGON A
      REDUCTION IN SEROTONIN 5HT(2) RECEPTOR-BINDING ON PLATELETS OF DELINQUENT ADOLESCENTS

      Psychopharmacology
    31. BARJOSEPH A; BERKOVITCH Y; ADAMCHIK J; BIEGON A
      NEUROPROTECTIVE ACTIVITY OF HU-211, A NOVEL NMDA ANTAGONIST, IN GLOBAL-ISCHEMIA IN GERBILS

      Molecular and chemical neuropathology
    32. SARA SJ; DEVAUGES V; BIEGON A; BLIZARD DA
      THE MAUDSLEY RAT STRAINS AS A PROBE TO INVESTIGATE NORADRENERGIC-CHOLINERGIC INTERACTION IN COGNITIVE FUNCTION

      JOURNAL OF PHYSIOLOGY-PARIS
    33. BIEGON A; EBERLING JL; RICHARDSON BC; ROOS MS; WONG STS; REED BR; JAGUST WJ
      HUMAN CORPUS-CALLOSUM IN AGING AND ALZHEIMERS-DISEASE - A MAGNETIC-RESONANCE-IMAGING STUDY

      Neurobiology of aging
    34. BIEGON A
      LIGAND DEVELOPMENT FOR IN-VIVO IMAGING OF MONOAMINE TRANSPORTERS

      Journal of neurochemistry
    35. BARJOSEPH A; BERKOVITCH Y; ADAMCHIK J; BIEGON A
      NEUROPROTECTIVE ACTIVITY OF HU-211 - DOSE-RESPONSE AND THERAPEUTIC WINDOW IN A GLOBAL-ISCHEMIA MODEL IN THE MONGOLIAN GERBIL

      Journal of neurochemistry
    36. ESHHAR N; STRIEM S; NADLER V; BIEGON A
      HU-211, A NON-PSYCHOTROPIC CANNABINOID AS A NOVEL NEUROPROTECTANT AGENT

      Journal of neurochemistry
    37. VERED M; BARJOSEPH A; BELAYEV L; BERKOVICH Y; BIEGON A
      ANTI-ISCHEMIA ACTIVITY OF HU-211, A NON-PSYCHOTROPIC SYNTHETIC CANNABINOID

      Acta neurochirurgica
    38. ESHHAR N; STRIEM S; BIEGON A
      HU-211, A NON-PSYCHOTROPIC CANNABINOID, RESCUES CORTICAL-NEURONS FROMEXCITATORY AMINO-ACID TOXICITY IN CULTURE

      NeuroReport
    39. SARA SJ; DEVAUGES V; BIEGON A
      MAUDSLEY RAT STRAINS, SELECTED FOR DIFFERENCES IN EMOTIONAL RESPONSES, DIFFER IN BEHAVIORAL-RESPONSE TO CLONIDINE AND IN [I-125] CLONIDINE BINDING IN THE LOCUS-CERULEUS

      Behavioural brain research
    40. BARJOSEPH A; BERCKOVICH Y; GREENBERGER V; BIEGON A
      NEUROPROTECTIVE ACTIVITY OF HU211, A NON-PSYCHOTROPIC SYNTHETIC CANNABINOID

      Journal of neurochemistry
    41. DYONLAURENT C; ROMAND S; BIEGON A; SARA S
      FUNCTIONAL REORGANIZATION OF THE NORADRENERGIC SYSTEM AFTER PARTIAL FORNIX SECTION - A BEHAVIORAL AND AUTORADIOGRAPHIC STUDY

      Experimental Brain Research
    42. JAGUST WJ; EBERLING JL; ROBERTS JA; BRENNAN KM; HANRAHAN SM; VANBROCKLIN H; ENAS JD; BIEGON A; MATHIS CA
      IN-VIVO IMAGING OF THE 5-HYDROXYTRYPTAMINE REUPTAKE SITE IN PRIMATE BRAIN USING SINGLE-PHOTON EMISSION COMPUTED-TOMOGRAPHY AND [I-123] 5-IODO-6-NITROQUIPAZINE

      European journal of pharmacology
    43. MATHIS CA; TAYLOR SE; BIEGON A; ENAS JD
      I-125! 5-IODO-6-NITROQUIPAZINE - A POTENT AND SELECTIVE LIGAND FOR THE 5-HYDROXYTRYPTAMINE UPTAKE COMPLEX .1. IN-VITRO STUDIES

      Brain research
    44. BIEGON A; MATHIS CA; HANRAHAN SM; JAGUST WJ
      I-125! 5-IODO-6-NITROQUIPAZINE - A POTENT AND SELECTIVE LIGAND FOR THE 5-HYDROXYTRYPTAMINE UPTAKE COMPLEX .2. IN-VIVO STUDIES IN RATS

      Brain research


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 03/08/20 alle ore 11:48:58